Drug
Fcm High Ferritin Target
Fcm High Ferritin Target: highest development phase Phase 3, developed by Vifor Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Vifor Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| FCM (Ferric carboxymaltose) high ferritin target NCT00994318 | Phase 3 | Iron Deficiency Anaemia |
Latest
No recent events.
Follow Fcm High Ferritin Target on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.